SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-037414
Filing Date
2023-03-28
Accepted
2023-03-28 08:19:07
Documents
4
Effectiveness Date
2023-03-28

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2310003d1_s8.htm S-8 41656
2 EXHIBIT 5.1 tm2310003d1_ex5-1.htm EX-5.1 5866
3 EXHIBIT 23.1 tm2310003d1_ex23-1.htm EX-23.1 1808
4 EX-FILING FEES tm2310003d1_ex-flingfees.htm EX-FILING FEES 17746
  Complete submission text file 0001104659-23-037414.txt   68198
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270891 | Film No.: 23766276
SIC: 2834 Pharmaceutical Preparations